1. Home
  2. PLX vs FCCO Comparison

PLX vs FCCO Comparison

Compare PLX & FCCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Protalix BioTherapeutics Inc. (DE)

PLX

Protalix BioTherapeutics Inc. (DE)

HOLD

Current Price

$1.71

Market Cap

204.9M

Sector

Health Care

ML Signal

HOLD

Logo First Community Corporation

FCCO

First Community Corporation

HOLD

Current Price

$29.36

Market Cap

222.9M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLX
FCCO
Founded
1993
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
204.9M
222.9M
IPO Year
1998
1998

Fundamental Metrics

Financial Performance
Metric
PLX
FCCO
Price
$1.71
$29.36
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$12.00
$30.00
AVG Volume (30 Days)
570.7K
20.1K
Earning Date
11-13-2025
01-21-2026
Dividend Yield
N/A
2.21%
EPS Growth
N/A
42.01
EPS
0.07
2.40
Revenue
$61,840,000.00
$74,180,000.00
Revenue This Year
$14.53
$22.64
Revenue Next Year
$75.77
$27.09
P/E Ratio
$24.25
$12.09
Revenue Growth
35.41
18.23
52 Week Low
$1.32
$19.46
52 Week High
$3.10
$29.55

Technical Indicators

Market Signals
Indicator
PLX
FCCO
Relative Strength Index (RSI) 35.14 66.28
Support Level $1.71 $26.96
Resistance Level $1.86 $29.40
Average True Range (ATR) 0.12 0.62
MACD -0.01 0.17
Stochastic Oscillator 16.67 97.19

Price Performance

Historical Comparison
PLX
FCCO

About PLX Protalix BioTherapeutics Inc. (DE)

Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.

About FCCO First Community Corporation

First Community Corp is a bank holding company. Along with its subsidiaries, it provides various banking products and services for professionals and small and medium-sized businesses, including consumer and commercial banking, mortgage, brokerage and investment, online banking, and insurance services. The company offers checking, savings, money market, individual retirement, and certificates of deposit accounts, and its lending lines include consumer loans, real estate loans, home improvement loans, home loans, flex loans, construction loans, agricultural loans, and others. The company's reportable segments are; Commercial and Retail Banking, which derives maximum revenue; Mortgage Banking; Investment Advisory and Non-Deposit; and Corporate.

Share on Social Networks: